Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Long-Term Debt Repayments (2016 - 2024)

Prestige Consumer Healthcare (PBH) has 15 years of Long-Term Debt Repayments data on record, last reported at $60.0 million in Q4 2024.

  • For Q4 2024, Long-Term Debt Repayments fell 7.69% year-over-year to $60.0 million; the TTM value through Sep 2025 reached $60.0 million, down 72.09%, while the annual FY2025 figure was $135.0 million, 40.0% down from the prior year.
  • Long-Term Debt Repayments reached $60.0 million in Q4 2024 per PBH's latest filing, up from $40.0 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $475.0 million in Q3 2021 and bottomed at -$352.0 million in Q1 2020.
  • Average Long-Term Debt Repayments over 5 years is $49.4 million, with a median of $55.0 million recorded in 2022.
  • Peak YoY movement for Long-Term Debt Repayments: tumbled 276.0% in 2020, then soared 541.89% in 2021.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $74.0 million in 2020, then plummeted by 32.43% to $50.0 million in 2021, then plummeted by 70.0% to $15.0 million in 2022, then surged by 333.33% to $65.0 million in 2023, then dropped by 7.69% to $60.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Repayments were $60.0 million in Q4 2024, $40.0 million in Q3 2024, and $35.0 million in Q2 2024.